Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -22.25% in 4 Weeks

Core Viewpoint - Phibro Animal Health (PAHC) has experienced significant selling pressure, resulting in a 22.3% decline in stock price over the past four weeks, but analysts anticipate better earnings than previously expected, indicating potential for recovery [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) for PAHC is currently at 27.99, suggesting that the stock is oversold and may be nearing a price reversal due to exhausted selling pressure [5]. - RSI is a momentum oscillator that ranges from 0 to 100, with readings below 30 typically indicating that a stock is oversold [2][3]. Group 2: Fundamental Indicators - There is a consensus among sell-side analysts that earnings estimates for PAHC have increased by 0.1% over the last 30 days, which often correlates with price appreciation in the near term [7]. - PAHC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further supporting the potential for a turnaround [8].